Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended on 30th June 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Johnson Pharmacare Limited has submitted a quarterly certificate from its Registrar & Share Transfer Agent, Satellite Corporate Services Private Limited, as required under SEBI Regulation 74(5) for the quarter ended 30th June 2026. The certificate confirms that no physical share certificates were received from shareholders for dematerialization during the quarter. This means all the company's shares are already held in dematerialized (demat) form and no physical certificates needed to be processed or cancelled. The filing was signed by Additional Director Nand Kishor Ray and submitted to BSE (Scrip Code 532154) on 13th July 2026.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that no physical shares were submitted for conversion to demat form during the quarter, indicating the company's shares are fully held in electronic form.